Soleus Capital Management, L.P. Ngm Biopharmaceuticals Inc Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $179,530 - $241,800	-13,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $483,280 - $616,560	-28,000 Reduced 68.29%	13,000 $230,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $826,149 - $1.07 Million	41,000 New	41,000 $862,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.